Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen F Butler

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Pain Medicine (Malden, Mass.)|December 17, 2009
Estimating attractiveness for abuse of a not-yet-marketed "abuse-deterrent" prescription opioid formulationStephen F Butler, Ryan Black, Jill M Grimes Serrano, et al.
The Journal of Nervous and Mental Disease|June 16, 2018
Burden of Schizophrenia or Psychosis-Related Symptoms in Adults Undergoing Substance Abuse EvaluationKimberlee J Trudeau, Joanna Burtner, Albert J Villapiano, et al.
The Clinical Journal of Pain|August 22, 2007
Internet surveillance: content analysis and monitoring of product-specific internet prescription opioid abuse-related postingsStephen F Butler, Synne Wing Venuti, Christine Benoit, et al.
Pain Medicine (Malden, Mass.)|October 13, 2017
Development and Validation of an Eight-Item Brief Form of the SOAPP-R (SOAPP-8)Ryan A Black, Stacey A McCaffrey, Albert J Villapiano, et al.
Journal of Opioid Management|May 28, 2013
Associations between public health indicators and injecting prescription opioids by prescription opioid abusers in substance abuse treatmentRyan A Black, Kimberlee J Trudeau, Theresa A Cassidy, et al.
Pharmacoepidemiology and Drug Safety|July 11, 2012
Measuring online endorsement of prescription opioids abuse: an integrative methodologyEmily C McNaughton, Ryan A Black, Mirella G Zulueta, et al.
Journal of Attention Disorders|August 1, 2013
Nonmedical use of prescription ADHD stimulant medications among adults in a substance abuse treatment population: early findings from the NAVIPPRO surveillance systemTheresa A Cassidy, Emily C McNaughton, Sajan Varughese, et al.
The Journal of Pain|December 1, 2009
Gender differences in risk factors for aberrant prescription opioid useRobert N Jamison, Stephen F Butler, Simon H Budman, et al.
Pain Medicine (Malden, Mass.)|December 14, 2017
Development of a Brief Version of the Current Opioid Misuse Measure (COMM): The COMM-9Stacey A McCaffrey, Ryan A Black, Albert J Villapiano, et al.
Journal of Substance Abuse Treatment|December 3, 2017
Understanding abuse of buprenorphine/naloxone film versus tablet products using data from ASI-MV® substance use disorder treatment centers and RADARS® System Poison CentersStephen F Butler, Ryan A Black, Stevan Geoffrey Severtson, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Pain Medicine (Malden, Mass.)|December 17, 2009
Estimating attractiveness for abuse of a not-yet-marketed "abuse-deterrent" prescription opioid formulationStephen F Butler, Ryan Black, Jill M Grimes Serrano, et al.
The Journal of Nervous and Mental Disease|June 16, 2018
Burden of Schizophrenia or Psychosis-Related Symptoms in Adults Undergoing Substance Abuse EvaluationKimberlee J Trudeau, Joanna Burtner, Albert J Villapiano, et al.
The Clinical Journal of Pain|August 22, 2007
Internet surveillance: content analysis and monitoring of product-specific internet prescription opioid abuse-related postingsStephen F Butler, Synne Wing Venuti, Christine Benoit, et al.
Pain Medicine (Malden, Mass.)|October 13, 2017
Development and Validation of an Eight-Item Brief Form of the SOAPP-R (SOAPP-8)Ryan A Black, Stacey A McCaffrey, Albert J Villapiano, et al.
Journal of Opioid Management|May 28, 2013
Associations between public health indicators and injecting prescription opioids by prescription opioid abusers in substance abuse treatmentRyan A Black, Kimberlee J Trudeau, Theresa A Cassidy, et al.
Pharmacoepidemiology and Drug Safety|July 11, 2012
Measuring online endorsement of prescription opioids abuse: an integrative methodologyEmily C McNaughton, Ryan A Black, Mirella G Zulueta, et al.
Journal of Attention Disorders|August 1, 2013
Nonmedical use of prescription ADHD stimulant medications among adults in a substance abuse treatment population: early findings from the NAVIPPRO surveillance systemTheresa A Cassidy, Emily C McNaughton, Sajan Varughese, et al.
The Journal of Pain|December 1, 2009
Gender differences in risk factors for aberrant prescription opioid useRobert N Jamison, Stephen F Butler, Simon H Budman, et al.
Pain Medicine (Malden, Mass.)|December 14, 2017
Development of a Brief Version of the Current Opioid Misuse Measure (COMM): The COMM-9Stacey A McCaffrey, Ryan A Black, Albert J Villapiano, et al.
Journal of Substance Abuse Treatment|December 3, 2017
Understanding abuse of buprenorphine/naloxone film versus tablet products using data from ASI-MV® substance use disorder treatment centers and RADARS® System Poison CentersStephen F Butler, Ryan A Black, Stevan Geoffrey Severtson, et al.
Pageof 8